Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Oncol Nurs Forum ; 34(4): 813-20, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17723973

ABSTRACT

PURPOSE/OBJECTIVES: To compare differences in the chemotherapy-induced nausea and vomiting (CINV) among three groups of women (acupressure, placebo acupressure, and usual care) undergoing chemo-therapy for breast cancer. DESIGN: A multicenter, longitudinal, randomized clinical trial throughout one cycle of chemotherapy. SETTING: Ten community clinical oncology programs associated with the M.D. Anderson Cancer Center and nine independent sites located throughout the United States. SAMPLE: 160 women who were beginning their second or third cycle of chemotherapy for breast cancer treatment and had moderate nausea intensity scores with their previous cycles. METHODS: Subjects were randomized to one of three groups: acupressure to P6 point (active), acupressure to SI3 point (placebo), or usual care only. Subjects in the acupressure group were taught to apply an acupressure wrist device by research assistants who were unaware of the active acupressure point. All subjects completed a daily log for 21 days containing measures of nausea and vomiting and recording methods (including antiemetics and acupressure) used to control these symptoms. MAIN RESEARCH VARIABLES: Acute and delayed nausea and vomiting. RESULTS: No significant differences existed in the demographic, disease, or treatment variables among the treatment groups. No significant differences were found in acute nausea or emesis by treatment group. With delayed nausea and vomiting, the acupressure group had a statistically significant reduction in the amount of vomiting and the intensity of nausea over time when compared with the placebo and usual-care groups. No significant differences were found between the placebo and usual-care groups in delayed nausea or vomiting. CONCLUSIONS: Acupressure at the P6 point is a value-added technique in addition to pharmaceutical management for women undergoing treatment for breast cancer to reduce the amount and intensity of delayed CINV. IMPLICATIONS FOR NURSING: Acupressure is a safe and effective tool for managing delayed CINV and should be offered to women undergoing chemotherapy for breast cancer.


Subject(s)
Acupressure/methods , Antineoplastic Agents/adverse effects , Breast Neoplasms/drug therapy , Nausea/chemically induced , Nausea/therapy , Vomiting/chemically induced , Vomiting/therapy , Age Factors , Antiemetics/therapeutic use , Female , Humans , Longitudinal Studies , Middle Aged , Nausea/drug therapy , Patient Satisfaction , Treatment Outcome , Vomiting/drug therapy
2.
Am J Health Behav ; 30(1): 51-61, 2006.
Article in English | MEDLINE | ID: mdl-16430320

ABSTRACT

OBJECTIVE: To examine factors influencing time from screening to final diagnosis among multicultural women with abnormal mammograms using the precede-proceed model. METHODS: Staff of 58 clinics and a sample of 436 women served by these clinics were interviewed and their medical records examined. RESULTS: Longer duration from screening to diagnosis was associated with speaking Spanish and having clinic staff make appointments. Ease of access to health care, provision of early morning screening services and higher levels of patient anxiety shortened the time to diagnosis. CONCLUSION: The precede-proceed model is useful in delineating personal and structural factors that affect timely diagnosis.


Subject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/ethnology , Continuity of Patient Care/statistics & numerical data , Mammography , Patient Acceptance of Health Care/ethnology , Aged , Anxiety , Black People , Breast Neoplasms/diagnostic imaging , California , Causality , Culture , Ethnicity/psychology , Factor Analysis, Statistical , Female , Humans , Interviews as Topic , Middle Aged , Risk Factors , Socioeconomic Factors , Time Factors
3.
Womens Health Issues ; 15(2): 55-63, 2005.
Article in English | MEDLINE | ID: mdl-15767195

ABSTRACT

OBJECTIVE: We conducted a randomized clinical trial to determine the impact on pain and image quality when breast cushions were used to pad the surfaces of the mammography equipment during film-screen mammography. METHODS: We recruited a consecutive volunteer sample of 394 participants. Breast cushions were used for only one breast, with laterality and sequence of use assigned randomly. Data collected from participants included demographic data, rating of pain from previous mammography, and rating of pain from present mammography using both a numeric rating scale and a visual analogue scale. Research assistants also collected breast compression and radiation exposure data. Radiologists were blinded to the laterality of cushion assignment while reading the mammograms and assessing image quality. RESULTS: Participants were primarily white women (75.3%), mean age 55.4 years. Most (94.4%) reported having previous mammography. Eight percent (n = 32) of those surveyed had thought about skipping or delaying mammography because of the pain involved. The pain associated with mammography was significantly (p < .001) less during oblique and craniocaudal views when breast cushions were used during the procedure. Retakes were required for 2% of the 1576 views with the most common reason being positioning (53%). CONCLUSION: The use of breast cushions significantly reduced the pain during film-screen mammography. Image quality with the cushions was reduced in a very small subset of women probably due to the difficulty in positioning the breast without visual clues. More research needs to be done prior to the routine use of these cushions in clinical practice.


Subject(s)
Mammography/methods , Pain/etiology , Pain/prevention & control , Women's Health , Adult , Aged , California , Equipment Design , Female , Humans , Mammography/standards , Middle Aged , Pain/psychology , Pain Measurement/methods , Patient Satisfaction/statistics & numerical data , Pressure , Single-Blind Method , Surveys and Questionnaires
4.
Womens Health Issues ; 14(2): 60-8, 2004.
Article in English | MEDLINE | ID: mdl-15120415

ABSTRACT

PURPOSE: The purpose of this study was to explore the similarities and differences between lesbians and their heterosexual sisters in the established risks for developing breast cancer. METHODS: The design for this study was a matched (lesbian with heterosexual sister) cross-sectional, mail-back, anonymous survey. We distributed the surveys throughout the state of California to English-speaking women who identified themselves as lesbians, age 40 and older, and their sisters. Using the modified Gail Breast Cancer Risk model as well as other well-established factors associated with the development of breast cancer, we compared the breast cancer risk potential for 324 sister pairs (N = 648). Data were analyzed using paired t-tests, analysis of covariance (ANCOVA), McNemar's chi(2), or the Bowker statistic, as appropriate for the level of data. MAIN FINDINGS: The lesbians had significantly higher 5-year (p <.0001) and lifetime (p =.001) risk for developing breast cancer. The reasons for lesbians' predicted rate of breast cancer were most likely their higher scores on all pregnancy-related variables and the relatively high number of breast biopsies they reported. The lesbians had used birth control pills less (p <. 0001), had significantly fewer pregnancies (p <.0001), children (p <.0001), abortions (p <.0001), and miscarriages (p <.0001) as well as significantly more breast biopsies (p =.02) than did their heterosexual sisters. CONCLUSIONS: A lesbian who comes out to her clinician is relying on the clinician to be informed and be open to discuss her life. When a lesbian has a lump or a suspicious mammogram, she needs her clinician to advocate for her within the health care system because she is at higher risk for having cancer than a heterosexual woman.


Subject(s)
Breast Neoplasms , Heterosexuality/statistics & numerical data , Homosexuality, Female/statistics & numerical data , Siblings , Women's Health , Adult , Breast Neoplasms/etiology , Breast Neoplasms/prevention & control , California , Chi-Square Distribution , Female , Humans , Middle Aged , Multivariate Analysis , Physician-Patient Relations , Quality of Life/psychology , Risk Assessment , Risk Factors , Self Disclosure , Surveys and Questionnaires , Time Factors
5.
Gerontologist ; 44(1): 76-84, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14978323

ABSTRACT

PURPOSE: Our goal was to identify factors predictive of mammography rescreening within 18 months of baseline screening in multiethnic, low-income older women. DESIGN AND METHODS: We interviewed a cross-sectional survey of staff of 102 randomly selected clinics that provided screening and diagnostic services. We also surveyed a random sample of 391 older women served by these clinics to retrospectively assess their experiences of the screening process. RESULTS: We found that 59% of the sample returned for a repeat mammogram. Education level and the belief it is important to get an annual mammogram were significant patient-level predictors of rescreening. Offering pap smears and using hands-on demonstrations with breast models were significant clinic-level variables predictive of rescreening. Of note, among the variables that did not prove significant in the final model were those reflecting ethnicity and income. IMPLICATIONS: Individual and health-care-delivery-system factors play important roles in the obtaining of regular mammograms by low-income women. These findings highlight the importance of both factors in improving rescreening rates among older women.


Subject(s)
Mammography , Mass Screening , Age Factors , Aged , Cross-Sectional Studies , Education , Ethnicity , Female , Health Status , Humans , Income , Middle Aged , Papanicolaou Test , Retrospective Studies , Time Factors , Vaginal Smears
6.
Oncol Nurs Forum ; 31(1): E1-8, 2004.
Article in English | MEDLINE | ID: mdl-14722600

ABSTRACT

PURPOSE/OBJECTIVES: To describe the incidence and intensity of vomiting in women receiving chemotherapy treatment for breast cancer since the advent of 5-HT3 antagonists. DESIGN: Longitudinal, descriptive. SETTING: 7 outpatient oncology clinics situated in hospitals, 5 outpatient oncology clinics associated with major teaching universities, 27 private outpatient oncology practices, and 1 outpatient clinic located in a county hospital. SAMPLE: Typical participants (N = 303) were 51.9 years, Caucasian (79%), married or partnered (65%), born U.S. citizens (93%), heterosexual (96%), living with someone (84%), and high school graduates (82%). METHODS: Baseline and poststudy questionnaires and a daily diary of vomiting through two cycles of chemotherapy (approximately two months) were used to collect data. MAIN RESEARCH VARIABLE: Vomiting experience. FINDINGS: The worst vomiting occurs three days after having chemotherapy for breast cancer. The types of oral antiemetics ordered for home use were changed between the two cycles of the study only 8% (n = 24) of the time. No demographic factors were associated with acute vomiting at times 1 or 2; younger age (r = -0.16; p = 0.012) was associated with more vomiting. Delayed vomiting was associated with age and body mass index, and younger, heavier women experienced more vomiting. Minority women (n = 55) reported significantly more delayed vomiting than did Caucasian women (mean = 6.56 versus 2.82; t = 2.02; p less than 0.05). CONCLUSIONS: Vomiting continues to be a significant problem for some women receiving chemotherapy for breast cancer. IMPLICATIONS FOR NURSING: Oncology nurses can use the results from this study to provide anticipatory guidance for patients undergoing chemotherapy for breast cancer and to support efforts to provide appropriate symptom management for these women.


Subject(s)
Antineoplastic Agents/adverse effects , Breast Neoplasms/drug therapy , Vomiting/chemically induced , Adult , Age Factors , Aged , Antiemetics/therapeutic use , Body Mass Index , Female , Humans , Incidence , Longitudinal Studies , Medical Records , Middle Aged , Serotonin 5-HT3 Receptor Antagonists , Serotonin Antagonists/therapeutic use , Severity of Illness Index , Socioeconomic Factors , Surveys and Questionnaires , Vomiting/drug therapy , Vomiting/epidemiology , Vomiting/nursing , Vomiting/prevention & control , White People
7.
Womens Health Issues ; 13(4): 167-74, 2003.
Article in English | MEDLINE | ID: mdl-13678808

ABSTRACT

Lesbians may be a higher risk subpopulation of women for cardiovascular disease due to the prevalence of risk factors and attitudes about weight. In a survey of 648 women, we compared various cardiovascular risk factors between 324 lesbians age 40 and older residing in California and their heterosexual sisters closest in age. Compared with their sisters, the lesbians had a significantly higher body mass index, waist circumference, and waist-to-hip ratio (WHR). The lesbians were also more likely to have ever smoked, but were as likely as their sisters to be current smokers. They were significantly less likely to have eaten red meat in the past year, but did not differ significantly from their sisters on the other nutritional variables. They were more likely, however, to report a history of weight cycling. With regard to exercise, the lesbians were significantly more likely to exercise at least weekly. Yet the two groups did not differ in the number of times per week exercised, the length of the exercise session, nor the exercise vigor. This is the first study to report waist circumference measurements and WHR for lesbians. Our findings suggest that lesbians, as a group, may have greater abdominal/visceral adiposity and, thus, a metabolic profile placing them at higher risk for cardiovascular disease. Future studies of cardiovascular risk in lesbians should measure low-density lipoprotein, C-reactive protein, and identifiers of the metabolic syndrome, namely blood pressure, triglyceride and high-density lipoprotein levels, and fasting glucose. Interventions designed to reduce abdominal/visceral adiposity in lesbians should also be examined in future studies.


Subject(s)
Heart Diseases/epidemiology , Homosexuality, Female , Attitude to Health , Body Constitution , Body Mass Index , California/epidemiology , Case-Control Studies , Cross-Sectional Studies , Exercise , Female , Heart Diseases/etiology , Humans , Middle Aged , Prevalence , Risk Factors , Smoking , Women's Health
8.
Oncol Nurs Forum ; 30(2): E40-7, 2003.
Article in English | MEDLINE | ID: mdl-12692669

ABSTRACT

PURPOSE/OBJECTIVES: To describe the experience and intensity of delayed nausea in women undergoing chemotherapy for breast cancer since the advent of the 5-HT3 antagonists. DESIGN: Multisite, longitudinal, descriptive. SETTING: 7 outpatient oncology clinics situated in hospitals, 5 outpatient oncology clinics associated with major teaching universities, 27 private outpatient oncology practices, and 1 outpatient clinic located in a county hospital. SAMPLE: Typical participants (N = 303) were 51.9 years old, Caucasian (79%), married or partnered (65%), born U.S. citizens (92%), heterosexual (96%), living with someone (83%), and high school graduates (82%). METHODS: Baseline and poststudy questionnaires plus a daily diary of nausea through two cycles of chemotherapy (approximately two months) were used to collect data. The Rhodes Inventory of Nausea, Vomiting, and Retching was used to assess the nausea experience. MAIN RESEARCH VARIABLES: Nausea. FINDINGS: The worst nausea occurred on the third day after having chemotherapy for breast cancer. The types of oral antiemetics ordered for home use were changed between the two cycles of the study only 8% (n = 24) of the time. Younger, heavier women experienced more delayed nausea. Women who had a history of nausea with stress and women receiving cyclophosphamide experienced more delayed nausea during both time periods. CONCLUSIONS: Delayed nausea is a significant problem for women receiving chemotherapy for breast cancer. IMPLICATION FOR NURSING: Oncology nurses can use the results from this study to provide anticipatory guidance for patients undergoing chemotherapy for breast cancer.


Subject(s)
Antiemetics/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Breast Neoplasms/nursing , Nausea/chemically induced , Nausea/nursing , Oncology Nursing/methods , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Female , Humans , Middle Aged , Nausea/drug therapy , Nausea/prevention & control , Outpatients , Surveys and Questionnaires , Time Factors
9.
Health Care Women Int ; 23(5): 450-9, 2002.
Article in English | MEDLINE | ID: mdl-12180426

ABSTRACT

Utilizing data from a cervical cancer screening program in California, we examined the relationship between being a woman of Asian/Pacific Islander (API) origin and receiving different types of abnormal cervical diagnoses. Initial descriptive data reflected a higher than expected percentage of API subjects with a final diagnosis of in situ and invasive cervical cancer when compared with other subjects in other ethnic groups (N = 2792). Results of multivariate analysis indicated that being of API origin retained significance in a model explaining the level of severity of the cervical final diagnosis, even when controlling for other significant predictors such as having a prior pap smear, age, referral source, the presence of cervical abnormalities and the time from screening to diagnosis. We conclude that women of API origin may not be accessing health care sufficiently early to prevent increasingly severe final diagnoses. Utilizing data from a cervical cancer screening program in California, we examined the relationship between being a woman of Asian/Pacific Islander (API) origin and receiving different types of abnormal cervical diagnoses. Initial descriptive data reflected a higher than expected percentage of API subjects with a final diagnosis of in situ and invasive cervical cancer when compared with other subjects in other ethnic groups (N = 2792). Results of multivariate analysis indicated that being of API origin retained significance in a model explaining the level of severity of the cervical final diagnosis, even when controlling for other significant predictors such as having a prior pap smear, age, referral source, the presence of cervical abnormalities and the time from screening to diagnosis. We conclude that women of API origin may not be accessing health care sufficiently early to prevent increasingly severe final diagnoses.


Subject(s)
Asian/statistics & numerical data , Mass Screening , Uterine Cervical Dysplasia/ethnology , Uterine Cervical Neoplasms/ethnology , Adult , California/epidemiology , Female , Humans , Middle Aged , Multivariate Analysis , Pacific Islands/ethnology , Risk Assessment , Uterine Cervical Neoplasms/diagnosis , Women's Health , Uterine Cervical Dysplasia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...